A Study of the Safety, Tolerance and Assessment of HE3286 on Insulin Sensitivity and Hepatic Glucose Production
Clinical trial NCT00991107 · COMPLETED
Trial details
- NCT number
- NCT00991107
- Sponsor
- Harbor Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-08-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.